Please assess the completion status of the following clinical trial:

Trial Title: Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or non-pregnant female \>=21 years of age~* A clinical diagnosis of critical limb ischemia (CLI) with Rutherford classification stage 5~* One or more chronic ulcers with a presumed etiology of arterial insufficiency and duration \>2 weeks. The target ulcer is defined as the highest-grade ulcer (Wagner's classification) at initial evaluation. For wounds with identical grading, the largest wound is the index wound~* The patient or legally authorized representative is willing to provide informed consent and comply with specified follow-up evaluations~* Undergoing intervention for infrainguinal or infrapopliteal artery disease (below the femoral artery bifurcation and above the ankle joint)~* The index procedure resulted in successful revascularization. For endovascular procedures, successful revascularization is defined as complete revascularization of the target ulcer culprit vessels according to the angiosome treatment strategy, with a final percent diameter stenosis \>50% and improved distal flow by angiography following the procedure. For surgical procedures, successful revascularization is defined as a patent graft and improved distal flow following the procedure.~Exclusion Criteria:~* Pregnant or nursing patients and those who plan pregnancy in the period up to 1 year following index procedure. Female patients of child-bearing potential must have a negative pregnancy test done within 7 days prior to index procedure.~* Rutherford classification stage 0,1,2,3,4, or 6~* Target wound duration \<2 weeks~* Presence of frank gangrene (Wagner classification grade 4 or 5), major tissue loss (severe/extensive necrosis), or unsalvageable limb (extensive ischemic ulceration beyond the transmetatarsal level anticipated to require major amputation after the index procedure)~* Previous or planned surgical or interventional procedure within 6 months before or 30 days after the index procedure, or any previous or planned target limb amputation.~* Active local or systemic infection~* Patients with ulcers judged by the examining physician to have a primary etiology other than ischemic arterial disease (e.g., venous related, decubitus, or other \[goug, pyoderma gangrenosum, necrobiosis lipoidica, vitamin B12 deficiency\])~* Renal failure or chronic kidney disease with estimated glomerular filtration rate (eGFR \<30 ml/min/1.7sm sq. within 30 days of the index procedure or treated with dialysis)~* Severly decreased cardiac output~* Uncontrolled hyperglycemia~* Patients with a known other medical illness or known history of substance abuse that may cause non-compliance with the protocol, confound data interpretation, or is associated with a life expectancy of less than 1 year~* Patient is currently participating (or has participated in the last 30 days) in a study of any other investigational treatment.~* Ulcer treatment with normothermic or hyperbaric oxygen therapy, recombinant or autologous growth factor products, or use of enzymatic debridement~* Concomitant medications such as corticosteroids, immunosuppressive medications, or chemotherapy~* Acute thrombus in the target limb

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OxyGenesys(TM) Dissolved Oxygen Dressing (Type: EXPERIMENTAL): OxyGenesys(TM) Dissolved Oxygen Dressing
- Standard Wound Care (Type: NO_INTERVENTION): Standard wound care using gauze dressings per institutional standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).